Automated Lead Optimization of MMP-12 Inhibitors Using a Genetic Algorithm.
about
Accessing new chemical entities through microfluidic systems.Future De Novo Drug Design.Target-Activated Prodrugs (TAPs) for the Autoregulated Inhibition of MMP12.Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug DiscoveryDesigning lead optimisation of MMP-12 inhibitors.
P2860
Automated Lead Optimization of MMP-12 Inhibitors Using a Genetic Algorithm.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Automated Lead Optimization of MMP-12 Inhibitors Using a Genetic Algorithm.
@ast
Automated Lead Optimization of MMP-12 Inhibitors Using a Genetic Algorithm.
@en
type
label
Automated Lead Optimization of MMP-12 Inhibitors Using a Genetic Algorithm.
@ast
Automated Lead Optimization of MMP-12 Inhibitors Using a Genetic Algorithm.
@en
prefLabel
Automated Lead Optimization of MMP-12 Inhibitors Using a Genetic Algorithm.
@ast
Automated Lead Optimization of MMP-12 Inhibitors Using a Genetic Algorithm.
@en
P2093
P2860
P356
P1476
Automated Lead Optimization of MMP-12 Inhibitors Using a Genetic Algorithm.
@en
P2093
Darren V S Green
David A Pardoe
David L Hunt
Ian Hughes
Stephen D Pickett
P2860
P356
10.1021/ML100191F
P577
2010-10-20T00:00:00Z